Clinical Trial Update: Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating novel α2-antiplasmin inactivation for lysis of intravascular thrombi in patients with pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• NAIL-IT

Snippet

Sponsor: Translational Sciences, Inc. | Conditions: Pulmonary Embolism | Phase 2 | Status: UNKNOWN